How We Help With Public Health Organizations Leavitt Partners’ experts have decades of experience working in the private and public health sectors as well as in the executive and legislative branches of the government. In response to this pandemic, Leavitt Partners has developed services to help clients address today’s urgency, while preparing for the new … Read more
How We Help Government Organizations Leavitt Partners offers a seasoned team of health care leaders and policy experts with extensive private- and public-sector experience across the health care industry. Our vast experience and significant policy expertise uniquely positions us to advise and inform clients on the impact of federal and state health care issues. Why … Read more
How We Help Associations Leavitt Partners empowers associations to succeed in the evolving health care ecosystem through informing and advising them on the latest industry trends and developments. Our innovative tools, cutting-edge research, and subject matter expertise helps associations find solutions to complex challenges and support their strategic-planning process. Why We’re Different Leavitt Partners has … Read more
Leavitt Partners examined publicly available resources to determine the 340B Drug Pricing Program’s (340B) impact on drug prices charged by both covered entities and pharmaceutical manufacturers. To answer these questions, Leavitt Partners undertook a comprehensive literature review of publicly available governmental reports, peer-reviewed journal articles, white papers, news articles, and other publicly available sources to … Read more
Nonadherence to a prescribed medication regimen for patients with chronic pain is associated with overall lower health outcomes, including increased hospital admissions, costs, and morbidity (quantitative review here). Deviations in timing, dosage, frequency, or duration of medication—all components of noncompliance—can cause medical reactions, increased pain, and medication use disorders, and can ultimately lead to emergency care … Read more
David Muhlestein, William K. Bleser, Robert S. Saunders, and Mark B. McClellan publish Health Affairs Blog “All-Payer Spread of ACOs and Value-Based Payment Models in 2021: The Crossroads and Future of Value-Based Care” Salt Lake City, June 17, 2021— Leavitt Partners and the Duke-Margolis Center for Health Policy released “All-Payer Spread of ACOs and Value-Based … Read more
Nutrition’s role in better health outcomes (both physical and mental) and potential cost savings is spurring increased innovation within the healthcare sector. Providers are increasingly interested in how to best connect their patients to quality food, which means that health plans are figuring if (and how) they will reimburse for increasing nutrition security. Here are … Read more
On April 16, 2021, Leavitt Partners held its bi-annual Political Checkpoint webinar, featuring Governor Mike Leavitt, Andrew Croshaw, Clay Alspach, and Sara Singleton. The topic of the discussion was focused on how the future direction of U.S. health policy has been changed by the events of the past year. Governor Leavitt provided a flyover of 20 … Read more
2020 was a year that no one could have predicted with the onset of the pandemic and its impact to the U.S. economy. As we head into 2021, the end of pandemic is in sight. However, we continue to see pervasive daily increases in coronavirus cases, high death rates, and continued challenges around the rollout … Read more
Salt Lake City, May 6, 2020 – As the U.S. begins to re-open on a localized level from precautions taken during this pandemic, forward-looking data is vital to our recovery. A continuously monitored short-term outlook on where the next potential outbreak may occur is critical for successful strategic response. Businesses, health care organizations, and public … Read more
